vs
Side-by-side financial comparison of Gain Therapeutics, Inc. (GANX) and TREASURE GLOBAL INC (TGL). Click either name above to swap in a different company.
TREASURE GLOBAL INC is the larger business by last-quarter revenue ($182.5K vs $105.4K, roughly 1.7× Gain Therapeutics, Inc.). TREASURE GLOBAL INC runs the higher net margin — -1169.1% vs -4255.7%, a 3086.6% gap on every dollar of revenue. TREASURE GLOBAL INC produced more free cash flow last quarter ($-2.4M vs $-6.1M).
Intellia Therapeutics, Inc. is an American clinical-stage biotechnology company focused on developing novel, potentially curative therapeutics leveraging CRISPR-based technologies. The company's in vivo programs use intravenously administered CRISPR as the therapy, in which the company's proprietary delivery technology enables highly precise editing of disease-causing genes directly within specific target tissues. Intellia's ex vivo programs use CRISPR to create the therapy by using engineere...
Treasure Global Inc is a consumer technology company offering integrated digital commerce solutions, customer loyalty rewards programs, and cashless payment services. It primarily operates across Southeast Asian markets, serving individual users and small-to-medium enterprise clients.
GANX vs TGL — Head-to-Head
Income Statement — Q3 FY2024 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $105.4K | $182.5K |
| Net Profit | $-4.5M | $-2.1M |
| Gross Margin | — | 0.7% |
| Operating Margin | -4230.3% | -953.5% |
| Net Margin | -4255.7% | -1169.1% |
| Revenue YoY | — | -12.0% |
| Net Profit YoY | 4.9% | -124.5% |
| EPS (diluted) | $-0.17 | $-0.38 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q3 25 | — | $182.5K | ||
| Q2 25 | — | $1.2M | ||
| Q1 25 | — | $666.5K | ||
| Q4 24 | — | $301.9K | ||
| Q3 24 | $105.4K | $207.4K | ||
| Q2 24 | $84.5K | $293.0K | ||
| Q1 24 | $115.3K | $1.6M | ||
| Q4 23 | — | $6.7M |
| Q3 25 | — | $-2.1M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $1.3M | ||
| Q4 24 | — | $-232.3K | ||
| Q3 24 | $-4.5M | $-950.7K | ||
| Q2 24 | $-8.1M | — | ||
| Q1 24 | $-4.0M | $-1.7M | ||
| Q4 23 | — | $-1.2M |
| Q3 25 | — | 0.7% | ||
| Q2 25 | — | 68.2% | ||
| Q1 25 | — | 73.0% | ||
| Q4 24 | — | 74.2% | ||
| Q3 24 | — | 83.0% | ||
| Q2 24 | — | 31.0% | ||
| Q1 24 | — | 13.6% | ||
| Q4 23 | — | 5.1% |
| Q3 25 | — | -953.5% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -6.5% | ||
| Q4 24 | — | -229.5% | ||
| Q3 24 | -4230.3% | -391.4% | ||
| Q2 24 | -9680.3% | — | ||
| Q1 24 | -3796.7% | -85.9% | ||
| Q4 23 | — | -16.2% |
| Q3 25 | — | -1169.1% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 189.0% | ||
| Q4 24 | — | -77.0% | ||
| Q3 24 | -4255.7% | -458.5% | ||
| Q2 24 | -9633.2% | — | ||
| Q1 24 | -3481.4% | -107.3% | ||
| Q4 23 | — | -17.9% |
| Q3 25 | — | $-0.38 | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $1.09 | ||
| Q4 24 | — | $-11.32 | ||
| Q3 24 | $-0.17 | $-17.62 | ||
| Q2 24 | $-0.42 | — | ||
| Q1 24 | $-0.22 | $-116.03 | ||
| Q4 23 | — | $-2.22 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $12.0M | — |
| Total DebtLower is stronger | $494.4K | — |
| Stockholders' EquityBook value | $8.9M | $12.0M |
| Total Assets | $14.4M | $16.6M |
| Debt / EquityLower = less leverage | 0.06× | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $2.5K | ||
| Q4 24 | — | $504.3K | ||
| Q3 24 | $12.0M | $44.1K | ||
| Q2 24 | $16.9M | $171.6K | ||
| Q1 24 | $12.7M | — | ||
| Q4 23 | — | — |
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $494.4K | — | ||
| Q2 24 | $486.4K | — | ||
| Q1 24 | $507.7K | — | ||
| Q4 23 | — | — |
| Q3 25 | — | $12.0M | ||
| Q2 25 | — | $10.7M | ||
| Q1 25 | — | $29.1M | ||
| Q4 24 | — | $18.4M | ||
| Q3 24 | $8.9M | $6.3M | ||
| Q2 24 | $11.8M | $3.4M | ||
| Q1 24 | $8.6M | $3.1M | ||
| Q4 23 | — | $3.7M |
| Q3 25 | — | $16.6M | ||
| Q2 25 | — | $14.9M | ||
| Q1 25 | — | $30.4M | ||
| Q4 24 | — | $19.1M | ||
| Q3 24 | $14.4M | $7.1M | ||
| Q2 24 | $19.2M | $4.3M | ||
| Q1 24 | $14.6M | $4.2M | ||
| Q4 23 | — | $4.9M |
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.06× | — | ||
| Q2 24 | 0.04× | — | ||
| Q1 24 | 0.06× | — | ||
| Q4 23 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-6.1M | $-1.8M |
| Free Cash FlowOCF − Capex | $-6.1M | $-2.4M |
| FCF MarginFCF / Revenue | -5764.6% | -1318.2% |
| Capex IntensityCapex / Revenue | 0.0% | 353.3% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | — | $-1.8M | ||
| Q2 25 | — | $-9.5M | ||
| Q1 25 | — | $-4.2M | ||
| Q4 24 | — | $-606.2K | ||
| Q3 24 | $-6.1M | $-976.3K | ||
| Q2 24 | $-5.8M | $-4.7M | ||
| Q1 24 | $-3.6M | $-1.1M | ||
| Q4 23 | — | $-1.2M |
| Q3 25 | — | $-2.4M | ||
| Q2 25 | — | $-9.5M | ||
| Q1 25 | — | $-4.2M | ||
| Q4 24 | — | — | ||
| Q3 24 | $-6.1M | — | ||
| Q2 24 | — | $-4.7M | ||
| Q1 24 | — | $-1.1M | ||
| Q4 23 | — | $-1.2M |
| Q3 25 | — | -1318.2% | ||
| Q2 25 | — | -822.4% | ||
| Q1 25 | — | -635.6% | ||
| Q4 24 | — | — | ||
| Q3 24 | -5764.6% | — | ||
| Q2 24 | — | -1614.2% | ||
| Q1 24 | — | -67.1% | ||
| Q4 23 | — | -17.9% |
| Q3 25 | — | 353.3% | ||
| Q2 25 | — | 1.3% | ||
| Q1 25 | — | 0.3% | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.0% | — | ||
| Q2 24 | — | 5.7% | ||
| Q1 24 | — | 0.0% | ||
| Q4 23 | — | 0.1% |
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -3.36× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
